63 and has a bile-duct/hilar stricture with biliary obstruction. Her CT/MRI reports have raised concern for possible...

CholangiocarcinomaNovember 6, 2026Written by Navis AI

Understanding Bile Cytology Results

The short answer: A negative bile cytology result is reassuring but unfortunately not definitive in ruling out cholangiocarcinoma. Here's why:

Sensitivity Limitations of Bile Cytology

Bile duct brushings and cytology have a significant limitation – they miss cancer cells in many cases even when cancer is present. According to medical literature:

  • Sensitivity ranges from 30-60% – meaning these tests detect cancer in only about one-third to two-thirds of actual cholangiocarcinoma cases
  • Specificity is high (95%+) – when cancer cells ARE found, the diagnosis is very reliable
  • Multiple negative samples don't rule out cancer – some patients require 3-4 brushings before cancer cells are detected, and some are never detected this way

Why the low sensitivity? Cholangiocarcinoma often grows along the bile duct wall in a way that makes it difficult to capture cancer cells with brushings. The tumor may be present but the brush simply doesn't collect the abnormal cells.

Tell us what’s going on with cholangiocarcinoma. 2 free answers, then a free account.

What "Inflammatory Smear" Tells Us

Your mother's result showing "inflammatory exudates comprising lymphocytes and neutrophils" indicates:

  • Active inflammation is present in the bile ducts
  • This is consistent with her clinical picture (fever/chills, obstruction, need for stenting)
  • Inflammation can be caused by:
    • The obstruction itself
    • Cholangitis (bile duct infection) – which her fever/chills suggest
    • Primary sclerosing cholangitis (PSC) or other inflammatory conditions
    • An underlying tumor causing irritation
    • The stent itself

Important context: According to NCCN Guidelines, cholangitis (bile duct infection) is a serious complication that requires immediate attention. The combination of fever, pain, and jaundice is significant and needs ongoing monitoring.

Clinical Decision-Making: How Doctors Approach This Situation

When faced with a suspicious stricture (narrowing) on imaging but negative cytology, oncologists typically consider several factors together:

The "Weight" of Different Findings:

High concern features (from imaging/clinical picture):

  • Stricture appearance on CT/MRI (irregular, mass-like, or causing significant obstruction)
  • Location at the hilum (where bile ducts meet) – called a Klatskin tumor when cancerous
  • Associated gallbladder lesion/polyp
  • Patient age and risk factors
  • Persistent obstruction requiring stenting
  • Recurrent cholangitis episodes

Reassuring features:

  • Negative cytology (though limited as discussed)
  • Inflammatory appearance on cytology
  • Absence of visible mass on imaging
  • Stable findings over time

What Typically Happens Next

According to NCCN Guidelines for biliary tract cancers, when there's imaging concern for cholangiocarcinoma but negative biopsies, doctors generally pursue:

1. Repeat sampling attempts:

  • Additional ERCP with brushings/biopsies
  • Endoscopic ultrasound (EUS) with fine-needle aspiration – can sample deeper tissue
  • Percutaneous biopsy if accessible

2. Advanced imaging:

  • High-quality MRI with MRCP (magnetic resonance cholangiopancreatography) if not already done
  • Sometimes PET scan to look for metabolic activity suggesting cancer

3. Biomarker testing:

  • CA 19-9 blood test (tumor marker) – though this can be elevated with obstruction/cholangitis even without cancer
  • CEA (carcinoembryonic antigen)
  • IgG4 levels to rule out autoimmune cholangitis

4. Close surveillance approach:

  • Serial imaging every 2-3 months
  • Monitor for changes in stricture appearance
  • Watch for development of mass or spread

5. Multidisciplinary review:

  • Your mother's case should be discussed by a team including gastroenterologists, radiologists, surgeons, and oncologists
  • They'll review all imaging, pathology, and clinical factors together

Questions to Ask Your Mother's Care Team

  1. "What specific features on the CT/MRI are concerning for cholangiocarcinoma versus benign stricture?" – Understanding the imaging characteristics helps gauge concern level

  2. "What is the plan for additional tissue sampling? Would EUS with FNA provide better samples than brushings?" – EUS can sometimes reach areas brushings cannot

  3. "Have we checked CA 19-9 and IgG4 levels? What were the results?" – These blood tests provide additional context

  4. "Could this be IgG4-related cholangitis or primary sclerosing cholangitis rather than cancer?" – Important alternative diagnoses to consider

  5. "What is the surveillance plan if we continue with watchful waiting? How often will imaging be repeated?"

  6. "At what point would you recommend proceeding with surgery even without definitive cancer diagnosis?" – Some strictures are removed surgically due to high suspicion despite negative biopsies

  7. "Should we get a second opinion from a hepatobiliary specialist or NCCN Cancer Center?" – Complex bile duct cases benefit from specialized expertise

  8. "How are we managing the cholangitis risk with the stents in place?" – Preventing infection is crucial for her quality of life

The Bottom Line

A negative bile cytology is one piece of information, but not the whole picture. In your mother's case, the clinical team must weigh:

  • ✓ Reassuring: Negative cytology, inflammatory findings
  • ⚠ Concerning: Stricture on imaging, location, gallbladder lesion, need for intervention

The imaging findings and clinical behavior of the stricture often carry more weight than a single negative cytology when determining next steps. Many cholangiocarcinomas are diagnosed based on imaging characteristics and clinical judgment, even with negative biopsies, because of the sampling limitations.

This is NOT a "wait and see if symptoms worsen" situation – it requires active surveillance with a clear plan for repeat evaluation.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Built by OpenCancer’s team of physician-scientists and cancer survivors.
  • Last updated November 6, 2026. Informational only — not a substitute for your oncology team.

Question asked:

My mother is 63 and has a bile-duct/hilar stricture with biliary obstruction. Her CT/MRI reports have raised concern for possible cholangiocarcinoma, and there is also a small gallbladder lesion/polyp mentioned. She has had biliary stents/drainage and episodes of fever/chills. Previous biopsy/brushings were negative for cancer. We just received another bile cytology report. It says: “Smear shows occasional epithelial cells with regular nuclei. Background showing inflammatory exudates comprising lymphocytes and neutrophils.” Impression: Inflammatory smear. So there are no malignant cells reported, only inflammation. How much weight should we give a negative bile cytology result?

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Services

Services that may help with general for Cholangiocarcinoma patients

More questions about Cholangiocarcinoma